Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
WuZi hot compress plaster is a Traditional Chinese Medicine (TCM) topical formulation developed by the Yueyang Integrated Traditional Chinese and Western Medicine Hospital, affiliated with the Shanghai University of Traditional Chinese Medicine. It is designed for the treatment of pain and discomfort associated with hyperplasia of mammary glands (breast hyperplasia). The "WuZi" (Five Seeds) name refers to the inclusion of five specific medicinal seeds, which typically include ingredients like Semen Sinapis (Bai Jie Zi) and Semen Raphani (Lai Fu Zi), known in TCM for their ability to promote Qi circulation, transform phlegm, and dissipate nodules. The plaster is applied topically to the breast area, often in conjunction with heat (hot compress) to enhance the transdermal absorption of the active botanical compounds. This therapeutic approach aims to reduce breast lumps and alleviate cyclic or non-cyclic mastalgia by improving local microcirculation and reducing inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on WuZi hot compress plaster.